SCHEMBL5913801

SCHEMBL5913801

CN(c1cccc(Cl)n1)c1ccnc([S+](C)[O-])n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5914113 0.80 MEN1 (0.39) —
SCHEMBL3924623 0.79 CYP3A4 (0.32) —
SCHEMBL24240133 0.76 RPS6KA5 (0.30) —
SCHEMBL5913947 0.74 LMNA (0.38) —
SCHEMBL5914308 0.71 AURKA (0.39) —
SCHEMBL5914182 0.71 CKS1B (0.31) —
SCHEMBL5913827 0.70 — —
SCHEMBL5914297 0.70 GABRA1 (0.38) —
SCHEMBL5914422 0.68 CYP1A2 (0.37) —
SCHEMBL21801997 0.66 NCF1 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060069110-A1 Substituted heterocyclic compounds and methods of use AMGEN INC. 2006-03-30 — — US disclosed
Send feedback